Rigel Pharmaceuticals, Inc. Share

Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel, targeted therapies to improve the lives of patients with hematologic disorders, cancer, and rare immune diseases. The company's research and development efforts are directed towards identifying and developing small molecule drugs that address critical unmet medical needs. Rigel's therapeutic candidates are designed to target specific signaling pathways involved in disease pathogenesis. The company's commitment extends to bringing innovative treatments to market and collaborating with partners to expand the reach of its therapies. Rigel operates within the dynamic and competitive biotechnology sector, striving to advance patient care through scientific innovation and rigorous clinical development.